Table 1 Mean values (± standard deviation) at initial evaluation of evaluation conducted for control and treatment groups.

From: Intraarticular triamcinolone hexacetonide, stanozolol, Hylan G-F 20 and platelet concentrate in a naturally occurring canine osteoarthritis model

 

CG

THG

HG

SG

PCG

Weight (kg. mean ± SD)

28.2 ± 6.2

26.5 ± 6.5

26.7 ± 3.5

27.1 ± 3.2

25.1 ± 9.6

Deviation (mean ± SD)

3.6 ± 2.7

4.7 ± 4.4

3.8 ± 3.5

4.3 ± 3.5

4.1 ± 2.2

Symmetry Index (mean ± SD)

24.8 ± 26.5

23.9 ± 50.4

21.7 ± 24.9

24.1 ± 13.9

22.6 ± 12.4

HVAS (0–10)

6.8 ± 1.2

5.7 ± 1.9

6.6 ± 1.4

6.7 ± 1.3

6.7 ± 1.4

PSS (0–10)

3.1 ± 1.9

4.2 ± 2.8

3.3 ± 2.6

2.9 ± 1.5

3.3 ± 2.6

PIS (0–10)

2.8 ± 1.7

4.8 ± 3.3

3.4 ± 2.3

2.3 ± 1.7

3.3 ± 2.8

LOAD (0–52)

13.6 ± 10.5

23.2 ± 14.1

17.0 ± 10.5

8.2 ± 5.2

13.3 ± 11.3

Stiffness (0–16)

3.4 ± 3.4

6.8 ± 4.2

3.4 ± 2.9

4.0 ± 2.8

3.9 ± 3.9

Function (0–16)

3.6 ± 4.1

6.3 ± 5.7

4.6 ± 3.5

4.0 ± 3.6

4.2 ± 4.7

Gait (0–20)

5.3 ± 3.9

10.5 ± 5.9

7.4 ± 4.7

5.2 ± 3.9

5.1 ± 5.4

QOL (0–12)

4.3 ± 2.5

6.2 ± 3.9

4.5 ± 3.1

4.3 ± 2.5

4.5 ± 3.6

COI (0–64)

17.6 ± 12.4

19.8 ± 19.1

19.9 ± 127

17.5 ± 12.4

17.7 ± 16.9

  1. CG Control group, THG Triamcinolone hexacetonide group, HG Hylan G-F 20 group, SG Stanozolol group, PCG Platelet concentrate group, HVAS Hudson Visual Analogue Scale, PSS Pain Severity Score, PIS Pain Interference Score, LOAD Liverpool Osteoarthritis in Dogs, QOL Quality of Life, COI Canine Orthopedic Index.